Zorubicin hydrochloride

Overview

Zorubicin hydrochloride is an anthracycline Antibiotic . Zorubicin hydrochloride exhibits activity against breast cancer , leukemia, and undifferentiated nasopharyngeal carcinoma. Zorubicin hydrochloride shows activity against undifferentiated nasopharyngeal carcinoma either as a monotherapy or in combination with Cisplatin ( HY-17394 ). Zorubicin hydrochloride can be used in research related to breast cancer , leukemia, and undifferentiated nasopharyngeal carcinoma.

Application

Products | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Nasopharyngeal Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Infection | Products > Disease Areas > Respiratory Cancer | Products > Disease Areas > Breast Cancer | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Antibiotic

Product Information

• Catalog No.: HY-183476
• CAS No.: 36508-71-1
• Molecular Formula: C34H36ClN3O10
• Molecular Weight: 682.12
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source